Tariffs tipped to cost Aussie pharma $1.6B

By Megan Brodie 1 year ago | In Companies, ESG, Industry
  • 1 year ago

11 April 2025 Australia’s healthcare and pharmaceuticals manufacturing sector is expected to face a disproportionate…

This is subscriber-only content. Please login to continue reading.